TRENDS IN SYNTHETIC BIOLOGY & AI IN DRUG DISCOVERY IN 2024

Summary from the TLDR AI newsletter

2024 is set to be a monumental year for AI in drug discovery, marking considerable advancements in synthetic biology. This article highlights key trends, including generative AI's influence on science and the synthesis of modular biological components. AI's integration with synthetic biology is accelerating the drug discovery process, as demonstrated by Insilico Medicine's AI-powered candidate's progression to Phase II clinical trials.